Literature DB >> 9491518

Radiation therapy and surgery for fibrosarcoma in 33 cats.

K Cronin1, R L Page, G Spodnick, R Dodge, E N Hardie, G S Price, D Ruslander, D E Thrall.   

Abstract

Thirty-three cats with histologically confirmed fibrosarcomas were treated with radiation therapy followed by surgery. The median (95% confidence interval) disease free interval and overall survival were 398 (261,924) and 600 (lower limit 515) days, respectively. There were 19 treatment failures; 11 cats had only local recurrence, 4 cats developed metastatic disease, 3 cats had local recurrence followed by metastasis, and 1 cat developed simultaneous local and distant disease. Twelve cats are alive and disease free. Two cats died without evidence of treatment failure. The presence of tumor cells at the margin of resected tissue after radiation was the only variable which influenced treatment success. The median (95% confidence interval) disease free interval in 5 cats with tumor cells at the margin of the resected specimen was 112 (94,150) days versus 700 (lower limit 328) days for 26 cats with negative tumor margins, p < 0.0001. We did not identify a relationship between tumor volume, number of prior tumor excisions, concomitant use of chemotherapy or various descriptors of the radiation therapy technique and disease free interval.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9491518     DOI: 10.1111/j.1740-8261.1998.tb00325.x

Source DB:  PubMed          Journal:  Vet Radiol Ultrasound        ISSN: 1058-8183            Impact factor:   1.363


  7 in total

1.  Three-dimensional hydrogel culture systems support growth and determination of chemosensitivity of feline sarcoma and carcinoma cell lines.

Authors:  Jacqueline V J Cavalcanti; Kimberly A Selting; Mai T Ngo; Christine K Tran Hoang; David J Schaeffer; Timothy M Fan; Brendan A C Harley; Heidi Phillips
Journal:  Am J Vet Res       Date:  2022-05-14       Impact factor: 1.055

2.  Temporal changes in characteristics of injection-site sarcomas in cats: 392 cases (1990-2006).

Authors:  Stephen C Shaw; Michael S Kent; Ira K Gordon; Cameron J Collins; Tamara A Greasby; Laurel A Beckett; Genevieve M Hammond; Katherine A Skorupski
Journal:  J Am Vet Med Assoc       Date:  2009-02-01       Impact factor: 1.936

3.  Photodynamic hyperthermal chemotherapy with indocyanine green in feline vaccine-associated sarcoma.

Authors:  Masaki Onoyama; Takeshi Tsuka; Tomohiro Imagawa; Tomohiro Osaki; Akihiko Sugiyama; Kazuo Azuma; Norihiko Ito; Kazuhiko Kawashima; Yoshiharu Okamoto
Journal:  Oncol Lett       Date:  2015-08-03       Impact factor: 2.967

Review 4.  Current knowledge on feline injection-site sarcoma treatment.

Authors:  Katarzyna Zabielska-Koczywąs; Anna Wojtalewicz; Roman Lechowski
Journal:  Acta Vet Scand       Date:  2017-07-17       Impact factor: 1.695

Review 5.  Vaccine-associated feline sarcoma: current perspectives.

Authors:  Corey F Saba
Journal:  Vet Med (Auckl)       Date:  2017-01-12

6.  Biological indicators of chemoresistance: an ex vivo analysis of γH2AX and p53 expression in feline injection-site sarcomas.

Authors:  Yike Bing; Zacharie Wund; Tina Abratte; Lucia Borlle; Susie Kang; Teresa Southard; Kelly R Hume
Journal:  Cancer Cell Int       Date:  2018-11-22       Impact factor: 5.722

7.  Origins of injection-site sarcomas in cats: the possible role of chronic inflammation-a review.

Authors:  Kevin N Woodward
Journal:  ISRN Vet Sci       Date:  2011-04-12
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.